Related Experiment Video
Updated: May 16, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes
Gustavo Saposnik1, David Gladstone, Roula Raptis
1MSc, FAHA, FRCPC, Stroke Outcomes Research Center, Department of Medicine, St. Michael's Hospital, University of Toronto, 55 Queen St E, Toronto, Ontario, M5C 1R6, Canada. saposnikg@smh.ca
Insights
Patients with atrial fibrillation (AF) face higher stroke mortality and hemorrhage risk. Thrombolysis showed no benefit for AF patients, unlike those without AF.
Area of Science:
- Neurology
- Cardiology
- Public Health
Background:
- Atrial fibrillation (AF) is a significant risk factor for stroke.
- AF is associated with poorer stroke outcomes and limited tools for evaluating treatment efficacy.
- Assessing clinical outcomes in AF stroke patients receiving thrombolysis is crucial.
Purpose of the Study:
- To evaluate the effectiveness of thrombolysis in acute ischemic stroke patients with and without atrial fibrillation.
- To assess clinical outcomes, including favorable outcomes, intracerebral hemorrhage, and mortality, in stroke patients with AF.
- To investigate the role of the iScore in predicting outcomes for stroke patients with AF.
Main Methods:
- Applied the validated iScore risk assessment tool to acute ischemic stroke patients.
- Analyzed data from the Registry of the Canadian Stroke Network.
- Defined favorable outcome as modified Rankin scale 0-2 at discharge; secondary outcomes included intracerebral hemorrhage and mortality.
Main Results:
- 17.2% of acute ischemic stroke patients had AF, exhibiting higher mortality and disability rates.
- Thrombolysis improved outcomes in non-AF patients but showed no benefit in AF patients.
- AF patients had a modestly increased risk of intracranial hemorrhage post-thrombolysis.
Conclusions:
- Stroke patients with AF experience higher mortality and intracerebral hemorrhage risk.
- Thrombolysis response in AF stroke patients is similar to non-AF patients, with no observed benefit.
- The iScore interacts with tPA treatment for favorable outcomes, particularly in non-AF patients.
Background And Purpose:
Atrial fibrillation (AF) increases the risk of stroke and is associated with poor stroke outcomes. Limited tools are available to evaluate clinical outcomes and response to thrombolysis in stroke patients with AF.
Methods:
We applied the iScore (http://www.sorcan.ca/iscore), a validated risk score, to consecutive patients with an acute ischemic stroke admitted to stroke centers in the Registry of the Canadian Stroke Network. The main outcome considered was a favorable outcome (defined as a modified Rankin scale 0-2) at discharge after thrombolysis. Secondary outcomes included intracerebral hemorrhage, death at 30 days, and at 1 year stratified by terciles of the iScore.
Results:
Among 12 686 patients with an acute ischemic stroke, 2185 (17.2%) had AF. Overall, AF patients had higher risk of death at 30 days (22.3% versus 10.2%; P<0.0001), 1 year (37.1% versus 19.5%; P<0.0001) and death or disability at discharge (69.7% versus 54.7%; P<0.0001) compared with non-AF patients. After adjustment, thrombolysis was associated with a favorable outcome for patients without AF (relative risk, 1.18; 95% CI, 1.10-1.27), but no benefit was observed for patients with AF (relative risk, 0.91; 95% CI, 0.71-1.17). There was a modestly increased risk of intracranial hemorrhage (any type) (16.5% versus 11.6%; relative risk, 1.42; 95% CI, 1.05-1.91) after thrombolysis among AF compared with non-AF patients. In the logistic regression analysis, there was an interaction between tPA and iScore for a favorable outcome (P-value interaction <0.001). The interaction also was significant (P<0.0012) among patients without AF, but did not reach significance (P=0.17) in patients with AF.
Conclusions:
Stroke patients with AF have higher mortality, greater risk of intracerebral hemorrhage, and a similar response trend to thrombolysis compared with non-AF patients.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Venous Thrombosis III: Interprofessional Care
Hemorrhagic Stroke ll: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

